Jupiter (JLHL) Q2 FY27 Hospitals' Profit Stalls Despite 16% Revenue Growth
The hospital chain's revenue hit a new high, but a 230 bps YoY margin squeeze kept profit flat, as expansion costs continue to weigh.
Jupiter Life Line Hospitals reported a 16% YoY revenue jump to ₹456.5 crore in Q2 FY27. However, profit slipped 1.9% to ₹56.36 crore as new hospital ramp-up costs compressed the net margin to 12.3%.
For Jupiter Life Line Hospitals, growth is a two-part story. The hospital chain is successfully filling new beds and driving revenue higher, but the cost of that expansion is landing squarely on the bottom line. The September quarter delivered a 16% year-on-year revenue jump, yet profit slipped slightly, a sign that the margin squeeze from its new Dombivli hospital is far from over.
Revenue rose to ₹456.5 crore, a new quarterly high, while profit after tax was ₹56.36 crore. Sequentially, profit rebounded 50% from a low base in the June quarter, but it remains below the level achieved a year ago. The net profit margin compressed by 230 basis points year-on-year to 12.3%.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 456.5YoY +16% | 410.98 | 393.63 |
| Profit (₹ Cr) | 56.36YoY -1.9% | 37.51 | 57.48 |
| Net Profit Margin (%) | 12.3YoY -16% | 9.1 | 14.6 |
The Expansion Drag
The primary tension is between growing revenue and shrinking margins. The 16% revenue growth was driven by a ramp-up at the newly commissioned 500-bed Dombivli hospital, higher patient volumes, and a favourable specialty mix, as reported by Informist Media. However, this new unit is still in its investment phase. According to research from DSIJ, the Dombivli hospital is operating at a 25-30% occupancy rate and continues to incur a monthly EBITDA loss.
These start-up losses, along with higher depreciation and finance costs for the expansion, are the main culprits behind the margin decline. The company's guidance, noted in a Q1 earnings call summary, is for this drag to continue, with Dombivli expected to reach EBITDA breakeven only in its second year of operation.
A Sequential Rebound, Not a Recovery
The sharp 50% quarter-on-quarter profit jump looks impressive, but it comes with a caveat. It is a rebound from an unusually weak base in Q1, when profit hit a five-quarter low of ₹37.51 crore due to the full impact of Dombivli's initial ramp-up costs. The Q2 profit of ₹56.36 crore is still below the ₹57.48 crore earned in the same period last year. This suggests the sequential improvement is a normalization from a trough, not a signal that margin pressures have abated.
The Road to Margin Recovery
Management's outlook hinges on occupancy gains at its newer hospitals. Reports indicate the Thane unit is mature, Pune has room to grow, and Indore is focused on ramping up. The key, however, is Dombivli. Its path to profitability depends on securing insurance empanelments and steadily increasing patient footfall over the next 12-18 months. Until then, the consolidated margin will bear the weight of this greenfield investment.
The balance sheet remains supportive for this growth phase. The company maintains a comfortable debt-to-equity ratio of 0.33, and management has indicated that internal accruals and existing cash should fund much of the near-term capital expenditure.
Key Points
- Revenue grew 16% YoY to ₹456.5 crore, but profit declined 1.9% to ₹56.36 crore, highlighting a margin squeeze.
- The net profit margin fell 230 bps YoY to 12.3%, pressured by ramp-up losses at the new Dombivli hospital.
- Profit rebounded 50% sequentially from a low Q1 base, but remains below the year-ago level.
- Occupancy ramp-up and insurance empanelment at Dombivli are critical for margin recovery over the next 1-2 years.
- The company's balance sheet is stable, with a debt-to-equity ratio of 0.33, supporting its expansion plans.
Hexa Perspective
Jupiter Hospitals is executing on its growth plan, with revenue scaling to new highs. The current phase, however, is about absorbing costs. The margin compression is a known, guided outcome of adding significant new capacity, not a failure of operations.
The investment case now turns on the timeline for Dombivli's ramp-up. If occupancy climbs as planned and losses narrow, the significant revenue base being built today should translate into stronger profit growth tomorrow. The next few quarters will test that transition, with investors watching for any acceleration in the new unit's path to breakeven.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.